Skip to main content
SpringerLink
Log in

Molecular Diagnosis of Gall Bladder Cancer

  • Chapter
  • First Online:
Book cover Molecular Diagnostics in Cancer Patients

Abstract

Worldwide, gallbladder cancer (GBC) is comparatively rare but highly fatal and the most common biliary tree malignancy with gender and geographical-specific predilections that associate with the incidence of cholelithiasis. Morphological feature and anatomic location of gallbladder along with asymptomatic and aggressive nature of the disease progression are ascribed to advance stage diagnosis, poor prognosis thereby compromising GBC patient’s survival rate. Only 20% of GBC patients are diagnosed early with cancer progression limited to gallbladder while rest of the patients are diagnosed with metastasis to adjacent or distant organs. Currently, the available treatment option includes surgical removal of the non-metastatic and small-sized tumor or radiation therapy and/or chemotherapy in advanced stages with various side effects accounting for global health burden. With the recent advancement in better understanding of GBC pathogenesis, several markers have been proposed and evaluated for diagnostic efficiency in GBC. However, none of the markers identified so far has been developed for routine screening examination for GBC and still, there is lack of appropriate molecular diagnostic markers for its early detection and improve prognoses. Till today the complete treatment of GBCs remains unsatisfactory and a major challenge facing a bottleneck. In this chapter, we will focus on the GBC pathogenesis, available diagnostic methods and recent development in the molecular diagnostic methods that may provide future research directions for early detection of this deadly disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sharma A, et al. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23(22):3978–98.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591–602.

    Article  CAS  PubMed  Google Scholar 

  3. Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am. 2014;94(2):343–60.

    Article  PubMed  Google Scholar 

  4. Kumar JR, et al. An objective assessment of demography of gallbladder cancer. J Surg Oncol. 2006;93(8):610–4.

    Article  PubMed  Google Scholar 

  5. Gabbi C, et al. Estrogen-dependent gallbladder carcinogenesis in LXRbeta−/− female mice. Proc Natl Acad Sci U S A. 2010;107(33):14763–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109.

    PubMed  PubMed Central  Google Scholar 

  7. Lai CH, Lau WY. Gallbladder cancer—a comprehensive review. Surgeon. 2008;6(2):101–10.

    Article  PubMed  Google Scholar 

  8. Tomita K, et al. Long-term survival of a recurrent gallbladder carcinoma patient with lymph node and peritoneal metastases after multidisciplinary treatments: a case report. Surg Case Rep. 2016;2(1):12.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Rai R, et al. A multiple interaction analysis reveals ADRB3 as a potential candidate for gallbladder cancer predisposition via a complex interaction with other candidate gene variations. Int J Mol Sci. 2015;16(12):28038–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dwivedi AN, Jain S, Dixit R. Gall bladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3(3):231–44.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Misra S, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167–76.

    Article  PubMed  Google Scholar 

  12. Shrikhande SV, et al. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause! Eur J Surg Oncol. 2010;36(6):514–9.

    Article  CAS  PubMed  Google Scholar 

  13. Nervi F, Duarte I, Gómez G, Rodríguez G, Del Pino G, Ferrerio O, et al. Frequency of gallbladder cancer in Chile, a high-risk area. Int J Cancer. 1988;41:657–60.

    Article  CAS  PubMed  Google Scholar 

  14. Hamdani NH, et al. Clinicopathological study of gall bladder carcinoma with special reference to gallstones: our 8-year experience from eastern India. Asian Pac J Cancer Prev. 2012;13(11):5613–7.

    Article  PubMed  Google Scholar 

  15. Lowenfels AB, et al. Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol. 1989;18(1):50–4.

    Article  CAS  PubMed  Google Scholar 

  16. Roa I, et al. Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case-control study. J Surg Oncol. 2006;93(8):624–8.

    Article  PubMed  Google Scholar 

  17. Biswas PK. Carcinoma gallbladder. Mymensingh Med J. 2010;19(3):477–81.

    CAS  PubMed  Google Scholar 

  18. Espinoza JA, et al. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta. 2016;1865(2):245–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbeck’s Arch Surg. 2001;386(3):224–9.

    Article  CAS  Google Scholar 

  20. Li Y, Zhang J, Ma H. Chronic inflammation and gallbladder cancer. Cancer Lett. 2014;345(2):242–8.

    Article  CAS  PubMed  Google Scholar 

  21. Sharma V, et al. Role of bile bacteria in gallbladder carcinoma. Hepato-Gastroenterology. 2007;54(78):1622–5.

    CAS  PubMed  Google Scholar 

  22. Andia ME, et al. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer. 2008;123(6):1411–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tewari M, Mishra RR, Shukla HS. Salmonella typhi and gallbladder cancer: report from an endemic region. Hepatobiliary Pancreat Dis Int. 2010;9(5):524–30.

    CAS  PubMed  Google Scholar 

  24. Tyagi BB, Manoharan N, Raina V. Risk factors for gallbladder cancer: a population based case-control study in Delhi. Indian J Med Pediatr Oncol. 2008;29:16–26.

    Article  Google Scholar 

  25. Shukla VK, et al. Carcinoma of the gallbladder—is it a sequel of typhoid? Dig Dis Sci. 2000;45(5):900–3.

    Article  CAS  PubMed  Google Scholar 

  26. Di Domenico EG, et al. Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer. Int J Mol Sci. 2017;18(9):1887.

    Article  PubMed Central  CAS  Google Scholar 

  27. Prieto AI, Ramos-Morales F, Casadesus J. Repair of DNA damage induced by bile salts in Salmonella enterica. Genetics. 2006;174(2):575–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rai A, Mohapatra SC, Shukla HS. A review of association of dietary factors in gallbladder cancer. Indian J Cancer. 2004;41(4):147–51.

    PubMed  Google Scholar 

  29. Makiuchi T, et al. The relationship between vegetable/fruit consumption and gallbladder/bile duct cancer: a population-based cohort study in Japan. Int J Cancer. 2017;140(5):1009–19.

    Article  CAS  PubMed  Google Scholar 

  30. Panda D, et al. Gall bladder cancer and the role of dietary and lifestyle factors: a case-control study in a North Indian population. Eur J Cancer Prev. 2013;22(5):431–7.

    Article  CAS  PubMed  Google Scholar 

  31. Li L, et al. Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: a meta-analysis of observational studies. Obesity (Silver Spring). 2016;24(8):1786–802.

    Article  CAS  Google Scholar 

  32. Tan W, et al. Body mass index and risk of gallbladder cancer: systematic review and meta-analysis of observational studies. Nutrients. 2015;7(10):8321–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Wang F, Wang B, Qiao L. Association between obesity and gallbladder cancer. Front Biosci (Landmark Ed). 2012;17:2550–8.

    Article  Google Scholar 

  34. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007;96(9):1457–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Liu H, et al. Body mass index can increase the risk of gallbladder cancer: a meta-analysis of 14 cohort studies. Med Sci Monit Basic Res. 2016;22:146–55.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Hsing AW, et al. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer. 2007;121(4):832–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Fernandez E, et al. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomark Prev. 1994;3(3):209–12.

    CAS  Google Scholar 

  38. Rai R, et al. p53: its alteration and gallbladder cancer. Eur J Cancer Prev. 2011;20(2):77–85.

    Article  CAS  PubMed  Google Scholar 

  39. Wistuba II, et al. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol. 1996;27(4):360–5.

    Article  CAS  PubMed  Google Scholar 

  40. Rashid A, et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res. 2002;8(10):3156–63.

    CAS  PubMed  Google Scholar 

  41. Wistuba II, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995;55(12):2511–5.

    CAS  PubMed  Google Scholar 

  42. Singh MK, et al. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol. 2004;19(8):916–21.

    Article  CAS  PubMed  Google Scholar 

  43. Saetta AA. K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. J Surg Oncol. 2006;93(8):644–9.

    Article  CAS  PubMed  Google Scholar 

  44. Roa I, et al. Preneoplastic lesions in gallbladder cancer. J Surg Oncol. 2006;93(8):615–23.

    Article  PubMed  Google Scholar 

  45. Segovia Lohse HA, Cuenca Torres OM. Prevalence and sequence of metaplasia-dysplasia-carcinoma of the gallbladder. A single centre retrospective study. Cir Esp. 2013;91(10):672–5.

    Article  PubMed  Google Scholar 

  46. Itoi T, et al. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol Int. 1996;46(5):333–40.

    Article  CAS  PubMed  Google Scholar 

  47. Kozuka S, et al. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50(10):2226–34.

    Article  CAS  PubMed  Google Scholar 

  48. Wan X, et al. Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore). 2014;93(27):e131.

    Article  Google Scholar 

  49. Dursun N, et al. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas. Arch Pathol Lab Med. 2012;136(11):1347–58.

    Article  PubMed  Google Scholar 

  50. Singh SK, et al. Mucinous carcinoma of the gall bladder—an incidental diagnosis of a rare variant. J Cancer Res Ther. 2015;11(4):1045.

    PubMed  Google Scholar 

  51. Maharaj R, et al. A case report of the clear cell variant of gallbladder carcinoma. Int J Surg Case Rep. 2017;32:36–9.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Zhang C, et al. A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature. Onco Targets Ther. 2016;9:5797–802.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Oohashi Y, et al. Adenosquamous carcinoma of the gallbladder warrants resection only if curative resection is feasible. Cancer. 2002;94(11):3000–5.

    Article  PubMed  Google Scholar 

  54. Rustagi T, Rai M, Menon M. Ruptured adenosquamous cell carcinoma of the gallbladder: case report and review of literature. Gastrointest Cancer Res. 2011;4(1):29–32.

    PubMed  PubMed Central  Google Scholar 

  55. Bazan F, et al. Metastatic gallbladder adenocarcinoma with signet-ring cells: a case report. J Med Case Rep. 2011;5:458.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Ahmad Z, Qureshi A. Primary signet ring cell carcinoma of gall bladder: report of an extremely rare histological type of primary gall bladder carcinoma. BMJ Case Rep. 2010;2010:bcr0420091782.

    PubMed  PubMed Central  Google Scholar 

  57. Guo KJ, Yamaguchi K, Enjoji M. Undifferentiated carcinoma of the gallbladder. A clinicopathologic, histochemical, and immunohistochemical study of 21 patients with a poor prognosis. Cancer. 1988;61(9):1872–9.

    Article  CAS  PubMed  Google Scholar 

  58. Eltawil KM, et al. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44(10):687–95.

    PubMed  Google Scholar 

  59. Monier A, et al. Neuroendocrine tumor of the gallbladder. Pol J Radiol. 2015;80:228–31.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Mezi S, et al. Neuroendocrine tumors of the gallbladder: a case report and review of the literature. J Med Case Rep. 2011;5:334.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Carrera C, Kunk P, Rahma O. Small cell carcinoma of the gallbladder: case report and comprehensive analysis of published cases. J Oncol. 2015;2015:304909.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Adachi T, et al. Gallbladder small cell carcinoma: a case report and literature review. Surg Case Rep. 2016;2(1):71.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Lee H, Choi HJ, Park IY. Small cell carcinoma of the gallbladder: a case report. Ann Hepatobiliary Pancreat Surg. 2017;21(3):168–71.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Al-Daraji WI, et al. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma. Am J Surg Pathol. 2009;33(6):826–34.

    Article  PubMed  Google Scholar 

  65. Husain EA, et al. Gallbladder sarcoma: a clinicopathological study of seven cases from the UK and Austria with emphasis on morphological subtypes. Dig Dis Sci. 2009;54(2):395–400.

    Article  CAS  PubMed  Google Scholar 

  66. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol. 2008;34(3):306–12.

    Article  CAS  PubMed  Google Scholar 

  67. Gourgiotis S, et al. Gallbladder cancer. Am J Surg. 2008;196(2):252–64.

    Article  PubMed  Google Scholar 

  68. Yang XW, et al. The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer. 2014;14:652.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Feng FL, et al. Role of radical resection in patients with gallbladder carcinoma and jaundice. Chin Med J. 2012;125(5):752–6.

    PubMed  Google Scholar 

  70. Wang YF, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol. 2014;20(14):4085–92.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Rana S, et al. Evaluation of CA 242 as a tumor marker in gallbladder cancer. J Gastrointest Cancer. 2012;43(2):267–71.

    Article  CAS  PubMed  Google Scholar 

  72. Chaube A, et al. CA 125: a potential tumor marker for gallbladder cancer. J Surg Oncol. 2006;93(8):665–9.

    Article  CAS  PubMed  Google Scholar 

  73. Xu XS, et al. Model based on alkaline phosphatase and gamma-glutamyltransferase for gallbladder cancer prognosis. Asian Pac J Cancer Prev. 2015;16(15):6255–9.

    Article  PubMed  Google Scholar 

  74. Ong SL, et al. Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature. HPB (Oxford). 2008;10(6):446–58.

    Article  Google Scholar 

  75. Singh TD, et al. Quantitative assessment of expression of lactate dehydrogenase and its isoforms 3 and 4 may serve as useful indicators of progression of gallbladder cancer: a pilot study. Indian J Clin Biochem. 2011;26(2):146–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Singh TD, et al. The liver function test enzymes and glucose level are positively correlated in gallbladder cancer: a cancer registry data analysis from north central India. Indian J Cancer. 2012;49(1):125–36.

    Article  CAS  PubMed  Google Scholar 

  77. Oikarinen H. Diagnostic imaging of carcinomas of the gallbladder and the bile ducts. Acta Radiol. 2006;47(4):345–58.

    Article  CAS  PubMed  Google Scholar 

  78. Recio-Boiles A, Babiker HM. Cancer, gallbladder. Treasure Island: StatPearls; 2018.

    Google Scholar 

  79. Inui K, Yoshino J, Miyoshi H. Diagnosis of gallbladder tumors. Intern Med. 2011;50(11):1133–6.

    Article  PubMed  Google Scholar 

  80. Kim HJ, et al. Diagnostic role of endoscopic ultrasonography-guided fine needle aspiration of gallbladder lesions. Hepato-Gastroenterology. 2012;59(118):1691–5.

    PubMed  Google Scholar 

  81. Kumaran V, et al. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol. 2002;12(8):1993–9.

    Article  PubMed  Google Scholar 

  82. Tan CH, Lim KS. MRI of gallbladder cancer. Diagn Interv Radiol. 2013;19(4):312–9.

    PubMed  Google Scholar 

  83. Andren-Sandberg A. Diagnosis and management of gallbladder cancer. N Am J Med Sci. 2012;4(7):293–9.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Vijayakumar A, et al. Early diagnosis of gallbladder carcinoma: an algorithm approach. ISRN Radiol. 2013;2013:239424.

    PubMed  Google Scholar 

  85. Kapoor A, Kapoor A, Mahajan G. Differentiating malignant from benign thickening of the gallbladder wall by the use of acoustic radiation force impulse elastography. J Ultrasound Med. 2011;30(11):1499–507.

    Article  PubMed  Google Scholar 

  86. Kumar R, et al. Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma. Clin Nucl Med. 2012;37(5):431–5.

    Article  PubMed  Google Scholar 

  87. Ramos-Font C, et al. Ability of FDG-PET/CT in the detection of gallbladder cancer. J Surg Oncol. 2014;109(3):218–24.

    Article  PubMed  Google Scholar 

  88. Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract–an update. Cancer Imaging. 2014;14:14.

    PubMed  PubMed Central  Google Scholar 

  89. De Moura DTH, et al. Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: systematic review and meta-analysis. Endosc Ultrasound. 2018;7(1):10–9.

    Article  PubMed  Google Scholar 

  90. Wang SN, et al. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma. Kaohsiung J Med Sci. 2006;22(2):53–9.

    Article  PubMed  Google Scholar 

  91. Asai T, et al. High frequency of TP53 but not K-ras gene mutations in Bolivian patients with gallbladder cancer. Asian Pac J Cancer Prev. 2014;15(13):5449–54.

    Article  PubMed  Google Scholar 

  92. Maurya SK, et al. Genetic aberrations in gallbladder cancer. Surg Oncol. 2012;21(1):37–43.

    Article  PubMed  Google Scholar 

  93. Kumari N, et al. Role of C-erbB2 expression in gallbladder cancer. Indian J Pathol Microbiol. 2012;55(1):75–9.

    Article  PubMed  Google Scholar 

  94. Pujani M, et al. Expression of human epidermal growth factor receptor (Her 2/neu) and proliferative marker Ki-67: association with clinicopathological parameters in gallbladder carcinoma. Asian Pac J Cancer Prev. 2016;17(8):3903–9.

    PubMed  Google Scholar 

  95. Kanthan R, et al. Gallbladder cancer in the 21st century. J Oncol. 2015;2015:967472.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Ma HB, et al. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol. 2005;11(5):744–7.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Srivastava V, et al. Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac J Cancer Prev. 2013;14(5):2711–5.

    Article  PubMed  Google Scholar 

  98. Kim K, et al. Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma. Pathol Oncol Res. 2014;20(2):409–15.

    Article  CAS  PubMed  Google Scholar 

  99. Roa JC, et al. Inactivation of CDKN2A gene (p16) in gallbladder carcinoma. Rev Med Chil. 2004;132(11):1369–76.

    PubMed  Google Scholar 

  100. Feng Z, et al. The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. Exp Mol Pathol. 2011;91(2):569–77.

    Article  CAS  PubMed  Google Scholar 

  101. Yao H, et al. The role of annexin A4 in cancer. Front Biosci (Landmark Ed). 2016;21:949–57.

    Article  CAS  Google Scholar 

  102. Huang HL, et al. Proteomic identification of tumor biomarkers associated with primary gallbladder cancer. World J Gastroenterol. 2014;20(18):5511–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  103. Yao HS, et al. Annexin A4-nuclear factor-kappaB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer. Sci Rep. 2016;6:31056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Jagannath P, Callery M. Molecular prognostic markers in gallbladder carcinoma. HPB (Oxford). 2012;14(9):571–2.

    Article  Google Scholar 

  105. Nagano M, et al. Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma. HPB (Oxford). 2012;14(9):573–82.

    Article  Google Scholar 

  106. Wu K, et al. ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients. Med Oncol. 2011;28(2):475–80.

    Article  CAS  PubMed  Google Scholar 

  107. Puhalla H, et al. E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue. Anticancer Res. 2005;25(6B):4249–54.

    CAS  PubMed  Google Scholar 

  108. Priya TP, et al. Role of E-cadherin gene in gall bladder cancer and its precursor lesions. Virchows Arch. 2010;456(5):507–14.

    Article  CAS  PubMed  Google Scholar 

  109. Yi S, et al. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas. Pathol Res Pract. 2014;210(6):363–8.

    Article  CAS  PubMed  Google Scholar 

  110. Nakamura T, et al. Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol. 2002;20(5):937–41.

    CAS  PubMed  Google Scholar 

  111. Luo W, et al. Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma. Oncol Lett. 2016;11(2):1345–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Saranga Bharathi R, et al. Female sex hormone receptors in gallbladder cancer. J Gastrointest Cancer. 2015;46(2):143–8.

    Article  CAS  PubMed  Google Scholar 

  113. Gupta P, et al. Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 2012;5(2):41–7.

    PubMed  PubMed Central  Google Scholar 

  114. Baskaran V, et al. Do the progesterone receptors have a role to play in gallbladder cancer? Int J Gastrointest Cancer. 2005;35(1):61–8.

    Article  CAS  PubMed  Google Scholar 

  115. Park JS, et al. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma. J Surg Res. 2009;152(1):104–10.

    Article  CAS  PubMed  Google Scholar 

  116. Sumi K, et al. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer. Oncol Rep. 2004;12(5):979–84.

    CAS  PubMed  Google Scholar 

  117. Chandra V, et al. MicroRNA aberrations: an emerging field for gallbladder cancer management. World J Gastroenterol. 2016;22(5):1787–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Li G, Pu Y. MicroRNA signatures in total peripheral blood of gallbladder cancer patients. Tumour Biol. 2015;36(9):6985–90.

    Article  CAS  PubMed  Google Scholar 

  119. Pang Q, et al. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J Gastroenterol. 2015;21(21):6675–83.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Zhang L, et al. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma. HPB (Oxford). 2016;18(7):600–7.

    Article  Google Scholar 

  121. Zhang Y, et al. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Clin Transl Oncol. 2015;17(10):810–8.

    Article  CAS  PubMed  Google Scholar 

  122. Saqib R, et al. Prognostic significance of pre-operative inflammatory markers in resected gallbladder cancer: a systematic review. ANZ J Surg. 2018;88(6):554–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    Rajani Rai, Saumyak Gosai & Vishal Chandra

  2. McAllen Family Medicine Residency Program, McAllen, TX, USA

    Saumyak Gosai

  3. Hematology/Oncology Section, Department of Medicine, Center for Cancer Prevention and Drug Development, Stephenson Cancer Center (SCC), University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA

    Chinthalapally V. Rao

Authors
  1. Rajani Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saumyak Gosai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chinthalapally V. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vishal Chandra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vishal Chandra .

Editor information

Editors and Affiliations

  1. Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India

    Kamla Kant Shukla

  2. Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India

    Praveen Sharma

  3. Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India

    Sanjeev Misra

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rai, R., Gosai, S., Rao, C.V., Chandra, V. (2019). Molecular Diagnosis of Gall Bladder Cancer. In: Shukla, K., Sharma, P., Misra, S. (eds) Molecular Diagnostics in Cancer Patients. Springer, Singapore. https://doi.org/10.1007/978-981-13-5877-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-5877-7_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-5876-0

  • Online ISBN: 978-981-13-5877-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation